There was a significant difference in ACE2 levels between the two sub-cohorts with distinct outcomes, showing a significant AUC value (0.6519) as well as Log-Rank p value (p = 0.0117) for the prediction of disease progression in severe COVID-19 conditions. Here, ACE2 is linked to COVID-19.